Relay Therapeutics, Inc. Earnings Per Share (Basic)
Relay Therapeutics, Inc. (RLAY) reported Earnings Per Share (Basic) of -$0.41 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- Relay Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-06-30 was -$0.41.
- Relay Therapeutics, Inc. earnings per share, basic for the quarter ending 2026-03-31 was -$0.41.
- Relay Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-09-30 was -$0.43.
- Relay Therapeutics, Inc. earnings per share, basic for the quarter ending 2025-06-30 was -$0.41.
- Relay Therapeutics, Inc. earnings per share, basic for fiscal 2025 was -$1.61.
- Relay Therapeutics, Inc. earnings per share, basic for fiscal 2024 was -$2.36.
- Relay Therapeutics, Inc. earnings per share, basic for fiscal 2023 was -$2.79.
- Relay Therapeutics, Inc. earnings per share, basic for fiscal 2022 was -$2.59.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.41 10-Q · filed 2026-08-06 | -$0.82 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | -$0.41 10-Q · filed 2026-05-05 | |||
| 2025-12-31 | -$1.61 10-K · filed 2026-02-26 | |||
| 2025-09-30 | -$0.43 10-Q · filed 2025-11-06 | -$1.30 10-Q · filed 2025-11-06 | ||
| 2025-06-30 | -$0.41 10-Q · filed 2026-08-06 | -$0.87 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | -$0.46 10-Q · filed 2026-05-05 | |||
| 2024-12-31 | -$2.36 10-K · filed 2026-02-26 | |||
| 2024-09-30 | -$0.63 10-Q · filed 2025-11-06 | -$1.94 10-Q · filed 2025-11-06 | ||
| 2024-06-30 | -$0.69 10-Q · filed 2025-08-07 | -$1.32 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | -$0.62 10-Q · filed 2025-05-05 | |||
| 2023-12-31 | -$2.79 10-K · filed 2026-02-26 | |||
| 2023-09-30 | -$0.54 10-Q · filed 2024-11-06 | -$2.12 10-Q · filed 2024-11-06 | ||
| 2023-06-30 | -$0.81 10-Q · filed 2024-08-06 | -$1.59 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | -$0.78 10-Q · filed 2024-05-02 | |||
| 2022-12-31 | -$2.59 10-K · filed 2025-02-26 | |||
| 2022-09-30 | -$0.76 10-Q · filed 2023-11-02 | -$2.04 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | -$0.71 10-Q · filed 2023-08-08 | -$1.28 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.57 10-Q · filed 2023-05-04 | |||
| 2021-12-31 | -$0.66 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$1.31 derived: net income ÷ weighted average shares · filed 2024-02-22 | -$3.82 10-K · filed 2024-02-22 | |
| 2021-09-30 | -$0.66 10-Q · filed 2022-11-03 | -$3.20 10-Q · filed 2022-11-03 | ||
| 2020-12-31 | -$5.40 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |